Bvf Has Lowered Chemocentryx (CCXI) Position by $862,370; Fairview Capital Investment Management Has Boosted Holding in Cheniere Energy (LNG)

Cheniere Energy, Inc. (NYSEAMERICAN:LNG) Logo

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 1.27% based on its latest 2018Q4 regulatory filing with the SEC. Bvf Inc sold 86,237 shares as the company’s stock rose 6.99% with the market. The hedge fund held 6.69 million shares of the health care company at the end of 2018Q4, valued at $72.96 million, down from 6.77 million at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $694.25 million market cap company. The stock decreased 0.17% or $0.02 during the last trading session, reaching $11.96. About 239,543 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 14, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END

Fairview Capital Investment Management Llc increased its stake in Cheniere Energy Inc (LNG) by 22.88% based on its latest 2018Q4 regulatory filing with the SEC. Fairview Capital Investment Management Llc bought 377,505 shares as the company’s stock rose 5.78% with the market. The hedge fund held 2.03 million shares of the public utilities company at the end of 2018Q4, valued at $120.02 million, up from 1.65 million at the end of the previous reported quarter. Fairview Capital Investment Management Llc who had been investing in Cheniere Energy Inc for a number of months, seems to be bullish on the $17.25B market cap company. The stock increased 2.16% or $1.42 during the last trading session, reaching $67.06. About 1.59 million shares traded. Cheniere Energy, Inc. (NYSEMKT:LNG) has risen 25.29% since May 14, 2018 and is uptrending. It has outperformed by 20.92% the S&P500. Some Historical LNG News: 18/04/2018 – Cheniere Sabine Pass LNG Tanker Tracker for April 18 (Table); 06/03/2018 – ETEnergyWorld: India’s first US-sourced natural gas shipment leaves from Cheniere Energy’s Sabine Pass | @ETEnergyWorld…; 17/05/2018 – Cheniere Energy, Inc. Announces Offer to Acquire Outstanding Shrs of Cheniere Energy Partners LP Holdings, LLC; 07/03/2018 – Cheniere Sabine Pass LNG Tanker Tracker for March 7 (Table); 14/03/2018 – Cheniere Sabine Pass LNG Tanker Tracker for March 14 (Table); 04/05/2018 – CHENIERE EXPECTS `GOOD’ 2019 AMID OTHER U.S. PROJECTS DELAYS; 22/05/2018 – S&PGR Affirms Cheniere Corpus Christi Holdings ‘BB-‘ Debt Rtg; 05/03/2018 Cheniere and GAIL Celebrate Commencement of 20-year LNG Contract; 07/03/2018 – Cheniere Has Opened Beijing Office — CERAWeek Market Talk; 07/05/2018 – CHENIERE ENERGY INC LNG.A : CITIGROUP RAISES TARGET PRICE TO $73 FROM $65

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.26 EPS, down 85.71% or $0.12 from last year’s $-0.14 per share. After $-0.23 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” on April 16, 2019, also Nasdaq.com with their article: “After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA – Nasdaq” published on March 11, 2019, Seekingalpha.com published: “ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 08, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference – GlobeNewswire” published on February 20, 2019 as well as Nasdaq.com‘s news article titled: “ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates – Nasdaq” with publication date: May 06, 2019.

Bvf Inc, which manages about $999.89 million and $765.19M US Long portfolio, upped its stake in Calithera Biosciences Inc (NASDAQ:CALA) by 754,282 shares to 3.30M shares, valued at $13.23M in 2018Q4, according to the filing. It also increased its holding in Infinity Pharmaceuticals Inc (NASDAQ:INFI) by 2.19M shares in the quarter, for a total of 17.43M shares, and has risen its stake in Merus N V.

Since January 7, 2019, it had 0 buys, and 5 insider sales for $1.38 million activity. Another trade for 6,172 shares valued at $74,079 was made by Cappel Markus J. on Thursday, January 10. Schall Thomas J. had sold 20,170 shares worth $242,370.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It is negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Morgan Stanley has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Clarivest Asset Management Limited invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). The Massachusetts-based Arrowstreet Capital Lp has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Geode Cap Mngmt Ltd invested in 333,917 shares. Credit Suisse Ag stated it has 10,418 shares. Dorsey Wright & Associate accumulated 1,170 shares. Fernwood Inv Mngmt Ltd Liability accumulated 10,000 shares or 0.07% of the stock. Alliancebernstein Limited Partnership stated it has 46,700 shares or 0% of all its holdings. Los Angeles Cap Equity Rech has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 19,032 shares. Aqr Capital Ltd Liability Com holds 22,364 shares or 0% of its portfolio. Citigroup holds 0% or 4,073 shares. Vanguard Grp has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Spark Invest Mgmt Ltd reported 0.09% stake. Wasatch has 2.32 million shares for 0.34% of their portfolio. Jpmorgan Chase And, New York-based fund reported 5,738 shares.

More notable recent Cheniere Energy, Inc. (NYSEAMERICAN:LNG) news were published by: Bizjournals.com which released: “Enbridge completes $3.3B acquisition of Spectra MLP – Houston Business Journal” on December 17, 2018, also Investorplace.com with their article: “Cold Winter and Increased Export Opportunities Make SWN Stock a Buy – Investorplace.com” published on November 07, 2018, Investorplace.com published: “5 Oil Stocks to Buy Even If Oil Prices Keep Falling – Investorplace.com” on December 19, 2018. More interesting news about Cheniere Energy, Inc. (NYSEAMERICAN:LNG) were released by: Nasdaq.com and their article: “Chesapeake Stock Can Be Rescued by Exports – Nasdaq” published on November 29, 2018 as well as Investorplace.com‘s news article titled: “A Risky Bet on Chesapeake Stock Could Frack Gains – Investorplace.com” with publication date: October 26, 2018.

Investors sentiment decreased to 1.24 in 2018 Q4. Its down 0.31, from 1.55 in 2018Q3. It is negative, as 40 investors sold LNG shares while 123 reduced holdings. 63 funds opened positions while 139 raised stakes. 227.40 million shares or 1.40% less from 230.63 million shares in 2018Q3 were reported. Whittier, a California-based fund reported 1,052 shares. Moreover, Sandy Spring Commercial Bank has 0% invested in Cheniere Energy, Inc. (NYSEAMERICAN:LNG). Wafra reported 125,110 shares. Oppenheimer Asset Mgmt Inc reported 0.01% stake. M&T Financial Bank reported 19,229 shares. National Asset Mgmt reported 0.07% stake. Hanseatic Mngmt holds 4,836 shares or 0.39% of its portfolio. Amundi Pioneer Asset Mngmt accumulated 67,635 shares or 0% of the stock. Harvest Fund Advisors Ltd Liability Company invested in 3.02% or 4.41M shares. Geode Cap Ltd Liability Co owns 0.04% invested in Cheniere Energy, Inc. (NYSEAMERICAN:LNG) for 2.02 million shares. Anchor Bolt Cap Limited Partnership holds 2.14 million shares. Hite Hedge Asset Mngmt Ltd Liability Co reported 3.46% in Cheniere Energy, Inc. (NYSEAMERICAN:LNG). Kingfisher Cap Limited Liability Company owns 30,630 shares for 1.29% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0.03% in Cheniere Energy, Inc. (NYSEAMERICAN:LNG). Fincl Bank Of New York Mellon Corp reported 2.40 million shares.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *